İlaç devi Synaptogenix ilk kez TAO satın alıyor, AI ve makine öğrenimi stratejisini şekillendiriyor

Synaptogenix, a biopharmaceutical company (NASDAQ: SNPX), announced its first purchase of TAO on Coin World, with the specific purchase amount undisclosed. This is part of the company's recent financial strategy focusing on artificial intelligence (AI) and machine learning in Kripto Varlıklar, choosing a platform to provide qualified partner management, Stake, and trading services for Synaptogenix's TAO assets.